
Michelle S. Chan
Partner
Areas of Focus
- Private Equity Transactions
- Private Equity
- Corporate & Finance
- Mergers & Acquisitions
- Corporate Governance
- Investment Management
- AgTech & FoodTech
- Private Capital
- Provides comprehensive advice on private equity and M&A transactions.
- Represents private equity funds and their portfolio companies, and institutional investors.
- Experience spans strategic and growth investments, M&A and corporate governance matters.
Michelle represents investment management and corporate clients on a broad array of complex business transactions. Her practice encompasses private equity and mergers & acquisitions (M&A), leveraged buyouts, divestitures, growth investments, minority investments, co-investments, corporate governance, board consents, equity grants and general corporate advice.
With clients across various industries, Michelle advises private equity funds and their portfolio companies, private and public companies and institutional investors, including sovereign wealth funds.
She also represents private equity sponsors, their portfolio companies and other strategic investors in related matters, including follow-on acquisitions, day-to-day corporate issues and corporate governance matters.
- Advised Paine Schwartz Partners–backed HGS BioScience, a leading provider of biological crop solutions, in its acquisition of:
- Pharmgrade, an Idaho-based innovator specializing in microbial consortium products.
- NutriAg Ltd., a Toronto-based innovator in bionutritional technologies.
- Advised Clear Channel Outdoor Holdings, Inc. and its subsidiaries in the completed sale of its business in Brazil to Publibanca Brasil S.A., an affiliate of Eletromidia S.A
- Represented Paine Schwartz Partners, a private equity fund specializing in sustainable food chain investing, in its strategic growth investment, in Elemental Enzymes, a leading developer of naturally occurring enzymes and biochemicals contributing to improved plant health, yield and profitability.
- Advised Tandym Group, a national consulting, recruitment and workforce solutions company backed by Mill Rock Capital, a growth and operations-oriented private investment firm that invests in well-positioned businesses in North America, and ICG, a global alternative asset manager, in its acquisition of:
- Certain assets of Entitech Solutions, a provider of tailored solutions for healthcare and life sciences organizations.
- Certain assets of Kolter Solutions, a technology staffing company specializing in healthcare IT.
- Certain assets of AETEA Information Technology (IT), a full spectrum IT human capital organization.
LanguagesCantonese
Cantonese
EducationJ.D., Columbia Law School, 2013
B.A., Dartmouth College, 2010
J.D., Columbia Law School, 2013
B.A., Dartmouth College, 2010
Bar AdmissionsNew York
New York
- Diversity Journal, Women Worth Watching in Leadership, 2024.
- The Legal 500 US, Private Equity Buyouts: Middle-Market (up to $500m), 2024.
- Moderator, “Hot Commodities in the Consumer Sector,” M&A Summit, Kayo Conference Series, October 2025.
- Moderator, “The New Normal: How to Get Deals Done,” Private Equity Summit, With Intelligence, March 2025.
- Moderator, “Making Portfolio Companies Successful: Why It’s Key to Making One’s Mark,” Private Equity Summit, With Intelligence, September 2023.

